CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top winning strategies
3.2.3 Top investment pockets
3.3 Market share analysis, 2014
3.4 Government regulations and reimbursement scenario
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Technological advancements
3.5.1.2 Large scale adoption in research and diagnosis applications
3.5.1.3 Increasing applications across novel fields
3.5.1.4 Augmented R&D investment
3.5.2 Restraints
3.5.2.1 High cost of instrument
3.5.2.2 Limited technical expertise
3.5.3 Opportunities
3.5.3.1 Lucrative opportunities in diagnostics in other diseases
3.5.3.2 Emerging role of flow cytometry in drug discovery and development
CHAPTER 4 AUSTRIA FLOW CYTOMETRY MARKET BY COMPONENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Instruments
4.2.1 Key market trends
4.2.2 Competitive landscape
4.2.3 Key growth factors and opportunities
4.2.4 Market size and forecast
4.2.5 Platforms
4.2.5.1 Market size and forecast
4.2.5.2 Sorters
4.2.5.2.1 MARKET SIZE AND FORECAST
4.2.5.3 Analysers
4.2.5.3.1 MARKET SIZE AND FORECAST
4.2.6 Replaceable components
4.2.6.1 Market size and forecast
4.2.6.2 Filters
4.2.6.2.1 MARKET SIZE AND FORECAST
4.2.6.3 Lasers
4.2.6.3.1 MARKET SIZE AND FORECAST
4.2.6.4 Detectors
4.2.6.4.1 MARKET SIZE AND FORECAST
4.2.6.5 Others
4.2.6.5.1 MARKET SIZE AND FORECAST
4.2.7 Accessories
4.2.7.1 Market size and forecast
4.3 Reagents and consumables
4.3.1 Key market trends
4.3.2 Competitive landscape
4.3.3 Key growth factors and opportunities
4.3.4 Market size and forecast
4.3.5 Antibodies
4.3.5.1 Market size and forecast
4.3.6 Dyes
4.3.6.1 Market size and forecast
4.3.7 Beads
4.3.7.1 Market size and forecast
4.3.8 Others
4.3.8.1 Market size and forecast
4.4 Software
4.4.1 Key market trends
4.4.2 Competitive landscape
4.4.3 Key growth factors and opportunities
4.4.4 Market size and forecast
4.5 Services
4.5.1 Key market trends
4.5.2 Competitive landscape
4.5.3 Key growth factors and opportunities
4.5.4 Market size and forecast
CHAPTER 5 AUSTRIA FLOW CYTOMETRY MARKET BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Bead-based flow cytometry
5.2.1 Key market trends
5.2.2 Competitive landscape
5.2.3 Key growth factors and opportunities
5.3 Cell based flow cytometers
5.3.1 Key market trends
5.3.2 Competitive landscape
5.3.3 Key growth factors and opportunities
CHAPTER 6 AUSTRIA FLOW CYTOMETRY MARKET BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Research applications
6.2.1 Key market trends
6.2.2 Competitive landscape
6.2.3 Key growth factors and opportunities
6.2.4 Market size and forecast
6.2.5 Cell cycle analysis and cell proliferation
6.2.6 Transfection and cell viability
6.3 Clinical applications
6.3.1 Key market trends
6.3.2 Competitive landscape
6.3.1 Key growth factors and opportunities
6.3.2 Market size and forecast
6.3.3 Apoptosis
6.3.4 Sorting/screening
6.4 Industrial applications
6.4.1 Key market trends
6.4.2 Competitive landscape
6.4.3 Key growth factors and opportunities
6.4.4 Market size and forecast
6.4.5 Organ transplantation
6.4.6 Hematological malignancies
6.4.7 Cancer and Solid Tumour
6.4.8 HIV
6.4.9 Others
CHAPTER 7 AUSTRIA FLOW CYTOMETRY MARKET BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Commercial organizations
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.3 Medical schools and clinical testing laboratories
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.4 Hospitals
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.5 Academic institutions
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.6 Others
CHAPTER 8 COMPANY PROFILES
8.1 Danaher Corporation (Beckman Coulter)
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Business performance
8.1.5 Key strategic moves and developments
8.1.6 SWOT analysis of Danaher Corporation
8.2 Becton, Dickinson And Co.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Business performance
8.2.5 Key strategic moves and developments
8.2.6 SWOT analysis of Becton, Dickinson and Co.
8.3 Merck Millipore
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business performance
8.3.4 Key strategic moves and developments
8.3.5 SWOT analysis of Merck Millipore
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Business performance
8.4.5 Key strategic moves and developments
8.4.6 SWOT analysis of Bio-Rad Laboratories, Inc.
8.5 Dako (Agilent Technologies)
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Business performance
8.5.5 Key strategic moves and developments
8.5.6 SWOT analysis of Agilent Technologies, Inc.